Novartis Investigative Site

Bothell, Washington 98011

0 studies enrolling now · 2 studies all time

What they study most

Major Depressive Disorder, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. — Completed
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder — Completed